Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03304587 · ClinicalTrials.gov registry record · NA
Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors
A NA study, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03304587 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 30 participants.
The verdict
NCT03304587, a NA study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will implement therapeutic bright light that is tailored to the individual's circadian typology and will estimate its effects on circadian rhythms, 4 common cancer-associated symptoms, and impact on quality of life in survivors living with cancer. Examining a selected phase marker (core body temperature) in relation to the associated clinical features (symptoms) is the starting point for future investigation of the biological mechanisms of symptoms.
Interventions
- DIAGNOSTIC_TEST Polysomnography (PSG)
- DIAGNOSTIC_TEST Rectal thermistor 400 Series
- OTHER Bright blue-green light
- OTHER Dim red light
- DIAGNOSTIC_TEST Digital foot candle datalogging light meter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03304587
The ClinicalTrials.gov registry entry for NCT03304587 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Polysomnography (PSG) is the first listed.
NCT03304587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03304587 about?
NCT03304587 is a clinical study titled "Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors". This study will implement therapeutic bright light that is tailored to the individual's circadian typology and will estimate its effects on circadian rhythms, 4 common cancer-associated symptoms, and impact on quality of life in survivors living with cancer. Examining a selected phase marker (core b...
What is the current status of trial NCT03304587?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-11-06. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT03304587?
The interventions under investigation include: Polysomnography (PSG) (DIAGNOSTIC_TEST), Rectal thermistor 400 Series (DIAGNOSTIC_TEST), Bright blue-green light (OTHER), Dim red light (OTHER), Digital foot candle datalogging light meter (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03304587?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.